Qualcomm is stepping out of its mobile comfort zone with a bold push into AI infrastructure. Its new inference-focused datacenter chips aim to challenge Nvidia and AMD with lower power draw and cost-efficient performance.
Stay up to date with curated collection of our top stories.
Deckers Outdoor’s stock stumbled despite solid Q3 results and resilient Hoka growth. With tariffs clouding guidance but free cash flow strong, the selloff looks overdone. At this valuation, the post-earnings drop offers long-term investors a rare entry point.
Most investors can name Buffett or Terry Smith. But a quieter elite of “quality purists” has been compounding capital far from the spotlight — from Montréal to Hong Kong, from Zurich to London. They buy great businesses, hold them for years, and let time do the heavy lifting.
After years of dominance, the quality factor has stumbled since mid-2024 as markets chased risk and valuations stretched. Narrow leadership and speculative fervor left steady earners behind—but shifting tides could soon restore quality’s quiet strength.
EPAM Systems unveiled a $1 billion share repurchase—roughly equal to its entire cash reserve. The bold move signals management’s conviction that the market undervalues the digital-engineering specialist’s long-term prospects.
For Marsh, Aon, WTW and Gallagher, AI looks less like a guillotine than a lever—stripping costs from placements, sharpening advisory clout, and spawning new insurable risks—even as it pressures small-ticket business. The winners weld data, governance and speed into advantage.
Behind the quiet hum of hospital labs lies one of healthcare’s toughest moats. Roche, Abbott, and Danaher have built diagnostics empires so entrenched that rivals can’t pry them loose—analyzers, reagents, and data all locking customers in for decades.
From IKEA to Spotify, Sweden keeps turning its modest size into a factory of world-class firms. The secret lies in long-term ownership, digital infrastructure, and a culture where ambition, trust, and design discipline quietly compound into global scale.
Moving money from employers to employees may seem simple, but in payroll, complexity is the moat. From ADP’s dominance to Paychex’s bold Paycor deal, the sector’s leaders thrive on compliance expertise, sticky customer relationships, and the financial cushion of client-fund float.
EPAM Systems built its reputation by solving the hard tech problems others avoided. Now, as generative AI reshapes software services, the company faces its defining test: can its engineering-first DNA turn AI disruption into a new era of growth and competitive advantage?
Marsh McLennan’s stock is down, but secular growth drivers remain. Can the risk-adviser giant still deliver for long-term investors?
Alcon's Q2 reporting was a slight miss. This does not mean that the structural story is broken. We buy the dip.
Cash may look simple, but valuing it rarely is. A dollar on the balance sheet can trade at a premium—or a discount—depending on how management is likely to use it. Academic research shows that the worth of “excess” cash hinges less on accounting than on trust.
Corporate culture is notoriously hard to measure, yet it may be the single most important driver of long-term corporate success.
Dual-class share structures have become the favorite shield of modern founders—and the headache of modern investors. By separating control from ownership, they let visionaries steer without interference but also weaken accountability as companies mature.
Intel’s third quarter showed a company slowly regaining its footing. Revenue ticked up, margins improved, and its foundry ambitions took shape—yet persistent losses and execution risks remind investors that this comeback, while real, remains fragile.
Lam Research delivered record margins on AI-fueled demand while warning China will fade under new curbs. Guidance dips on tariffs and mix, but 2026 growth bets rest on HBM, taller NAND stacks and EUV patterning—where Lam’s etch/deposition moat is deepest.
Novo Nordisk faces rare boardroom turmoil as its controlling foundation pushes for a sweeping overhaul. Chair Helge Lund and six directors are set to be replaced by a new slate led by ex-CEO Lars Rebien Sørensen—signaling a sharper, U.S.-focused pivot in the obesity-drug race.
Positive evERA data make giredestrant a real contender in HR+/HER2– breast cancer. Late-line use points to ~$1B peak; earlier-line wins could multiply that.
Novo’s Wegovy pill matches injection in weight loss, widening access as rivals like Lilly push oral GLP-1s in a fast-heating obesity race.
Rollins has turned pest control into a dependable, subscription-like cash machine—growing organically, tucking in bolt-on deals and keeping churn low. With a seasoned bench, dense routes and disciplined pricing, the company keeps margins steady even as rivals regroup.
Linde quietly dominates industrial gases with dense networks, proprietary engineering and long-term take-or-pay contracts that pass through energy costs, keeping cash flows steady.
SIG’s shopping spree—Scholle IPN and Evergreen—blurred its aseptic razor-blade edge, lifted leverage, and squeezed margins. The reset hands Ola Rollén a clear brief: prune the commodity pieces, migrate what’s upgradeable to aseptic economics, and rebuild the core duopoly story.
Amrize, Holcim’s U.S. spin-off, pairs irreplaceable quarries with premium roofing—and trades at a discount to peers. A long-term buy.
After years of inflation-fueled price hikes, Europe’s bake-off industry faces tighter margins and fiercer retailer negotiations. With input costs easing, growth now depends on volume, mix, and efficiency rather than pricing power.
EssilorLuxottica’s best quarter since the merger shows momentum is real. Smart glasses, premium lenses, and a thriving retail engine turned Q3 into a breakthrough—suggesting the eyewear giant’s tech-infused growth story is just getting started.
Nestlé’s new CEO is taking tough action: 16,000 job cuts, sharper portfolio focus, and a push for RIG-led growth—real demand, not just pricing. After years of inflation-driven gains, the world’s biggest food group is betting on leaner operations and genuine volume recovery.